secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0000950170-24-114467
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum receives Nasdaq delisting notice, hearing set for Nov 21 on equity compliance
--------------------------------------------------------------------------------

- Nasdaq notified Iterum on Oct 1 of delisting for failing to meet $2.5M stockholders' equity requirement after Sep 30 extension deadline.
- Company requested hearing; Nasdaq Hearings Panel will consider appeal on November 21, 2024.
- Trading of ITRM ordinary shares continues on Nasdaq Capital Market pending hearing outcome.
- Panel may grant compliance extension up to March 31, 2025, but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/0000950170-24-114467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/itrm-20241009.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-114467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer